STOCK TITAN

Bristol Myers (NYSE: BMY) EVP Gregory Meyers reports RSU vesting and tax-share withholding

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Bristol Myers Squibb executive Gregory Scott Meyers reported equity compensation activity involving restricted stock units and common shares. On February 1, 2026, 2,543 restricted stock units vested and converted into 2,543 shares of common stock at an exercise price of $0, reflecting previously granted awards that vest annually in four equal installments beginning on February 1, 2023.

On the same date, 833 common shares were withheld at a price of $55.05 to cover taxes due upon vesting of the restricted stock units. After these transactions, Meyers directly owned 21,428 shares of Bristol Myers Squibb common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Meyers Gregory Scott

(Last) (First) (Middle)
BRISTOL-MYERS SQUIBB COMPANY
ROUTE 206 AND PROVINCE LINE ROAD

(Street)
PRINCETON NJ 08543

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Digital & Tech Off.
3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.10 par value 02/01/2026 M 2,543(1) A $0 22,261 D
Common Stock, $0.10 par value 02/01/2026 F 833(2) D $55.05 21,428 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (3) 02/01/2026 M 2,543 (1) 02/01/2026 Common Stock, $0.10 par value 2,543 $0 0 D
Explanation of Responses:
1. The restricted stock units vest annually in four equal installments beginning on February 1, 2023.
2. Shares withheld for payment of taxes upon vesting of restricted stock units.
3. Each restricted stock unit converts into one share of common stock upon vesting.
Remarks:
/s/ Amy Fallone, attorney-in-fact for Gregory Scott Meyers 02/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BMY executive Gregory Scott Meyers report?

Gregory Scott Meyers reported the vesting of 2,543 restricted stock units that converted into the same number of Bristol Myers Squibb common shares on February 1, 2026. This reflects previously granted equity awards tied to his role as EVP, Chief Digital & Tech Officer.

How many Bristol Myers Squibb (BMY) shares were withheld for taxes in this Form 4?

The filing shows 833 Bristol Myers Squibb common shares withheld at $55.05 per share to pay taxes triggered by vesting restricted stock units. This is a common administrative transaction rather than an open-market sale for investment purposes.

How many BMY shares does Gregory Scott Meyers own after this Form 4?

After the reported transactions, Gregory Scott Meyers directly owns 21,428 shares of Bristol Myers Squibb common stock. This figure reflects the vested restricted stock units and the shares withheld to satisfy tax obligations on February 1, 2026.

What do the restricted stock units in the BMY Form 4 represent?

The restricted stock units represent equity awards that vest over time and convert into common shares. According to the filing, they vest annually in four equal installments beginning February 1, 2023, with each unit converting into one Bristol Myers Squibb common share upon vesting.

Was the BMY insider transaction an open-market purchase or sale?

The Form 4 shows no open-market trade. It reports restricted stock units converting into common shares at $0 and shares withheld at $55.05 solely to cover taxes. These are routine equity compensation and tax-withholding entries, not discretionary market buying or selling.

What is Gregory Scott Meyers’ role at Bristol Myers Squibb (BMY)?

Gregory Scott Meyers is identified as an officer of Bristol Myers Squibb, serving as EVP, Chief Digital & Tech Officer. The reported restricted stock units and common stock transactions relate to his compensation as a senior executive at the company.
Bristol-Myers Squibb Co

NYSE:BMY

BMY Rankings

BMY Latest News

BMY Latest SEC Filings

BMY Stock Data

113.78B
2.03B
0.07%
82.82%
1.53%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
PRINCETON